产品创新与研发

Search documents
韩妆品牌再“瘦身” 悦诗风吟关店求生
Bei Jing Shang Bao· 2025-07-07 09:13
近日,曾是"平价战斗机"的韩妆品牌悦诗风吟(Innisfree)关闭了其天猫海外旗舰店,但天猫国内旗舰店、抖音旗舰店等本土化渠道仍正常运营。从巅峰时 期年销40亿元、门店超800家,到如今营收暴跌62%、线下全面撤店,悦诗风吟的溃败折射出韩妆品牌在中国市场的集体困境。 渠道调整 业内人士指出,随着"韩流"热度减退,韩妆品牌吸引力下降,而国货美妆正在崛起,并以高性价比、贴合本土需求的产品迅速抢占市场。在韩妆自身发展 中,部分品牌深陷质量问题,且长期依赖营销,产品创新与研发投入不足,难以满足中国消费者对天然、功效型产品的升级需求。 在北京已无独立门店的悦诗风吟,如今则正式关停了其天猫海外旗舰店。此次品牌关闭的店铺主要销售韩国原产商品。而悦诗风吟的天猫国内旗舰店渠道仍 正常运营,中国本土生产的商品暂未受影响。此外,其京东自营、抖音官方旗舰店等线上渠道也仍正常营业。对于此次调整,悦诗风吟母公司爱茉莉太平洋 回应称,这是品牌为进一步整合资源、开辟并致力于构建更高效渠道采取的举措,旨在为消费者提供更优质的服务与互动体验。 悦诗风吟也曾在中国市场炙手可热。2012年进入中国后,凭借"韩流"效应和高性价比策略迅速崛起。201 ...
兴齐眼药:多方面驱动因素支持盈利增长 产品创新与研发是核心驱动力
Zheng Quan Shi Bao Wang· 2025-04-29 10:26
Core Viewpoint - The company, Xingqi Eye Pharmaceutical, reported strong financial performance for 2024, with significant growth in revenue and net profit, driven by product innovation and effective marketing strategies [1][4]. Financial Performance - In 2024, the company achieved operating revenue of 1.943 billion yuan, a year-on-year increase of 32.42% - Net profit reached 338 million yuan, up 40.84% year-on-year - The non-deductible net profit was 348 million yuan, reflecting a growth of 44.54% - Basic earnings per share were 1.94 yuan, with a distribution plan of 4 shares for every 10 shares and a cash dividend of 10 yuan (tax included) [1]. Research and Development - The company has consistently prioritized R&D, with investments of 190 million yuan, 181 million yuan, and 235 million yuan over the past three years, representing 15.22%, 12.38%, and 12.11% of operating revenue respectively - Plans to enhance R&D efforts include expanding the product line in the ophthalmology sector and strengthening the biopharmaceutical layout for retinal diseases [2][3]. - Currently, the company holds 60 approved ophthalmic drug licenses, with 38 products included in the medical insurance directory and 6 in the national essential drug list [2]. Market Strategy - The ophthalmology industry is experiencing growth in market size, technological innovation, and competition, while facing challenges from policy changes - The company emphasizes talent development and has established a comprehensive marketing support system to enhance the professional capabilities of its marketing team [3]. - A customer-centric and academically driven marketing management model has been adopted, supported by a multi-tiered marketing network and partnerships with major distributors across the country [3]. Growth Drivers - Key drivers of the company's profit growth include product innovation and R&D, market expansion and marketing efforts, cost control, and operational efficiency improvements - The company aims to implement a comprehensive development strategy focused on sustainable profit growth, guided by principles of innovation, quality, and shared growth [4].